DXCM Q2 2024 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$27B

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.0B+15.3% YoY

Gross Profit

$627M62.4% margin

Operating Income

$158M15.7% margin

Net Income

$144M14.3% margin

EPS (Diluted)

$0.35

QoQ Revenue Growth

+9.0%

Cash Flow

Operating Cash Flow

$279M

Free Cash Flow

$213M

Stock-Based Comp.

$45M

Balance Sheet

Total Assets

$6.8B

Total Liabilities

$4.4B

Stockholders' Equity

$2.4B

Cash & Equivalents

$939M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.0B	$871M	+15.3%
Gross Profit	$627M	$546M	+14.7%
Operating Income	$158M	$128M	+23.3%
Net Income	$144M	$116M	+23.8%

Geographic Segments

UNITED STATES

$732M73%

Non-US

$272M27%